← Back to Search

Optical Imaging for Gastrointestinal Disorders

N/A
Waitlist Available
Led By Guillermo Tearney, M.D, PhD.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up imaging data is collected during the procedure, and analyzed within 1 year of collection.
Awards & highlights

Study Summary

This trial is testing new optical imaging technologies to see if they can be used to detect and diagnose diseases of the gastrointestinal system without being destructive or invasive.

Who is the study for?
This trial is for individuals scheduled for an elective esophagoduodenoscopy and/or colonoscopy, typically procedures to look inside the stomach and colon. It's not open to those who don't meet the Massachusetts General Hospital (MGH) endoscopy department's standard care criteria.Check my eligibility
What is being tested?
The study is testing a new optical imaging device designed to image gastrointestinal biopsy samples. The goal is to see if this technology can help diagnose diseases of the gastrointestinal system without being too invasive or damaging tissue.See study design
What are the potential side effects?
Since this trial involves imaging already-scheduled biopsy samples with a new device, there are no direct side effects from the intervention itself. However, standard risks associated with biopsies still apply.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~imaging data is collected during the procedure, and analyzed within 1 year of collection.
This trial's timeline: 3 weeks for screening, Varies for treatment, and imaging data is collected during the procedure, and analyzed within 1 year of collection. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Device Feasibility based on image quality and presence of microscopic features

Trial Design

1Treatment groups
Experimental Treatment
Group I: Development of novel optical imaging technologiesExperimental Treatment1 Intervention
Consented participants will allow their endoscopist to collect 3 additional biopsies from the participants. These biopsies will be used to develop our imaging techniques at our lab. We will use the standard of care histology images from the endoscopy procedure as a control comparison.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,931 Previous Clinical Trials
13,198,245 Total Patients Enrolled
Guillermo Tearney, M.D, PhD.Principal InvestigatorMassachusetts General Hospital
6 Previous Clinical Trials
440 Total Patients Enrolled

Media Library

Biopsy imaged by Optical imaging device. Clinical Trial Eligibility Overview. Trial Name: NCT04565704 — N/A
Gastrointestinal Disease Research Study Groups: Development of novel optical imaging technologies
Gastrointestinal Disease Clinical Trial 2023: Biopsy imaged by Optical imaging device. Highlights & Side Effects. Trial Name: NCT04565704 — N/A
Biopsy imaged by Optical imaging device. 2023 Treatment Timeline for Medical Study. Trial Name: NCT04565704 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research trial currently enrolling participants?

"This study is not currently recruiting, as per the information displayed on clinicaltrials.gov; with its initial posting occurring on March 25th 2016 and its last update being made in September of 2020. There are presently 78 other medical trials searching for participants though."

Answered by AI

Who else is applying?

What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology
Guillermo Tearney 2016. "Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04565704.
~15 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top